Legal Representation
Attorney
Nicole E. Reifman
USPTO Deadlines
Next Deadline
1166 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230404)
Due Date
April 04, 2029
Grace Period Ends
October 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 4, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 4, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 9, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 3, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 2, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 2, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 13, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Class 005
Pharmaceutical preparations for the treatment of cancerous, inflammatory, immunological, and viral diseases; pharmaceutical preparations for use in the field of oncology, immunology, and inflammation for the treatment of cancer, asthma, atopic dermatitis, peripheral inflammatory diseases, cardiovascular disease, autoimmune diseases; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Classification
International Classes
001
005